American Bio Medica (ABMC) Short Interest Ratio & Short Volume

Short interest is the volume of American Bio Medica shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 100 shares of ABMC short. 0.00% of American Bio Medica's shares are currently sold short. Learn More on American Bio Medica's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABMC shares currently have a short interest ratio of 1.0. Learn More on American Bio Medica's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of American Bio Medica's floating shares are currently sold short.

0.00% of American Bio Medica's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to American Bio Medica: NovAccess Global Inc. (0.00%), RegeneRx Biopharmaceuticals, Inc. (0.01%), Sienna Biopharmaceuticals, Inc. (0.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

Short selling ABMC is an investing strategy that aims to generate trading profit from American Bio Medica as its price is falling. ABMC shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for American Bio Medica occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABMC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABMC, twice per month. The most recent reporting period available is March, 15 2025.